Walleye Capital
ROIV icon

Walleye Capital’s Roivant Sciences ROIV Stock Holding History

Walleye Capital’s Portfolio ROIV Stock Details ROIV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.49M Sell
98,733
-55,350
-36% -$1.64M 0.01% 1063
2026
Q1 		$4.27M Buy
154,083
+104,593
+211% +$2.69M 0.02% 902
2025
Q4 		$1.07M Buy
+49,490
New +$976K ﹤0.01% 2375
2025
Q3 		– Sell
-4,647
Closed -$57.5K – 5043
2025
Q2 		$52.4K Buy
+4,647
New +$50.4K ﹤0.01% 4019
2025
Q1 		– Sell
-200
Closed -$2.37K – 5010
2024
Q4 		$2.37K Buy
+200
New +$2.37K ﹤0.01% 4654
2024
Q2 		– Sell
-121
Closed -$1.33K – 5941
2024
Q1 		$1.27K Sell
121
-471,882
-100% -$5.09M ﹤0.01% 5305
2023
Q4 		$5.3M Buy
+472,003
New +$4.6M 0.01% 1074

Other funds holding ROIV

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
QF
QVT Financial New York $1.7B AUM 173.77% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return

Walleye Capital's ROIV Position: Q2 2026 in Review

Walleye Capital reduced its Roivant Sciences (ROIV) stake by 36% in Q2 2026, selling an estimated $1.64M and leaving 98,733 shares worth $3.49M. The position accounts for 0.01% of the portfolio, ranked #1063.

Walleye Capital first reported a position in ROIV in Q4 2023 and has held it in 7 quarters since. The position peaked at $5.3M in Q4 2023. 499 funds tracked by Wall St. Rank hold ROIV as of Q2 2026.

  • Walleye Capital held 98,733 shares of Roivant Sciences worth $3.49M as of Q2 2026.
  • Walleye Capital sold 55,350 Roivant Sciences shares in Q2 2026, an estimated $1.64M.
  • Roivant Sciences made up 0.01% of Walleye Capital's portfolio in Q2 2026, its #1063 holding.
  • Walleye Capital first reported a position in Roivant Sciences in Q4 2023 and has held it in 7 quarters since.
  • Walleye Capital's Roivant Sciences position peaked at $5.3M in Q4 2023.
  • 499 funds tracked by Wall St. Rank held Roivant Sciences as of Q2 2026.

Based on Walleye Capital's 13F filing for Q2 2026, filed 3 Aug 2026.